Question 1

What is the catalog number for ST-CY14?

Accepted Answer

The catalog number for ST-CY14 is orb2942767.

Question 2

What sizes are available for ST-CY14?

Accepted Answer

ST-CY14 is available in the following size(s): 50 mg, 10 mg.

Question 3

How many pack sizes does ST-CY14 come in?

Accepted Answer

ST-CY14 is available in 2 different pack sizes.

Question 4

Is ST-CY14 in stock?

Accepted Answer

ST-CY14 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is ST-CY14 used for?

Accepted Answer

ST-CY14 is a small molecule inhibitor that disrupts the Nur77-PPARγ interaction (Kd=32 nM), thereby stabilizing Nur77 and suppressing lipid metabolism genes like CD36 and FABP4. It inhibits breast cancer cell proliferation and migration in vitro and reduces tumor growth and bone metastasis in mouse

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 7

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 8

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

ST-CY14

Product Specifications

Field of Research

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

NDUFA4L2 Polyclonal Antibody

NDUFA4L2 Polyclonal Antibody

NDUFA4L2 Polyclonal Antibody

Lentiviral mouse Ints2 shRNA (UAS) - Lentiviral mouse Ints2 shRNA (UAS, RFP) (100)

HC-258

Bevacizumab (anti-VEGF)